Published in Drug Week, March 31st, 2006
Cipralex is an allosteric serotonin-reuptake inhibitor antidepressant, which has consistently shown significant efficacy, fast onset of action, and excellent tolerability in the treatment of depression and anxiety disorders in multiple clinical trials, according to the company. Superior efficacy of Cipralex in comparison with other existing antidepressants has been established in other clinical trials and several meta-analyses,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.